季节性流感疫苗对儿童呼吸道合胞病毒住院的非特异性益处:基于人群数据的工具变量分析
该研究利用2000-2013年西澳大利亚州全州儿童免疫、出生、死亡、住院及微生物检测等概率链接数据,以2008年州资助学龄前流感疫苗接种政策作为工具变量,评估季节性流感疫苗对实验室确诊呼吸道合胞病毒(RSV)住院的因果影响。结果显示,接种流感疫苗降低了RSV住院率,<2岁儿童每1000人减少2.27例(95%CI:-3.26至-1.28),2-7岁儿童每1000人减少0.53例(95%CI:-1.04至-0.02)。2008-2013年州资助学龄前流感疫苗项目使RSV住院减少1193例,其中793例(67%)为<2岁儿童。
要点
- 接种流感疫苗可降低儿童RSV住院率,<2岁儿童每1000人减少2.27例(95%CI:-3.26至-1.28)。
- 2-7岁儿童每1000人减少0.53例(95%CI:-1.04至-0.02)。
- 2008-2013年州资助项目使RSV住院减少1193例,其中793例(67%)为<2岁儿童。
核心结论
- 季节性流感疫苗接种对儿童RSV住院具有小的保护效应,该效应需进一步研究。
研究设计与样本
- 基于人群的观察性研究,使用2000-2013年西澳大利亚州所有2000-2012年出生儿童的概率链接数据,以2008年州资助学龄前流感疫苗接种政策为工具变量,建立两个联立概率单位方程进行估计。
主要发现
- 2008年前流感疫苗覆盖率低,2009年6-23月龄儿童覆盖率升至36%。
- 90%的RSV住院发生在<2岁儿童中。
- 接种流感疫苗使<2岁儿童RSV住院率每1000人减少2.27例(95%CI:-3.26至-1.28),使2-7岁儿童每1000人减少0.53例(95%CI:-1.04至-0.02)。
- 2008-2013年州资助学龄前流感疫苗项目使RSV住院减少1193例,其中793例(67%)为<2岁儿童。
局限性
- 作者指出该保护效应较小,需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Seasonal influenza vaccine is effective against influenza hospitalisations, but little is known about non-specific effects of the vaccine on other respiratory pathogens with similar seasonal patterns. We aimed to assess the causal impact of seasonal influenza vaccine on laboratory-confirmed hospitalisations for respiratory syncytial virus (RSV) in children using an instrumental variable (IV) strategy. METHODS: We used probabilistically linked population-based data on childhood immunisations, births, deaths, hospitalisations, perinatal factors, and microbiology test results (2000-2013) of all Western Australian (WA) children born 2000-2012, observed longitudinally until the earliest of 7 years of age or 31 December 2013. We exploited a unique natural experiment created from the WA's state-funded preschool influenza vaccination policy commencing in 2008 and used this as an instrument for children's seasonal influenza vaccination status. We estimated a system of two simultaneous probit equations: determinants of influenza vaccine uptake, and determinants of RSV-confirmed hospitalisation. RESULTS: Influenza vaccine coverage was low prior to 2008 but increased to 36 % in children aged 6-23 months in 2009. The majority (90 %) of RSV-hospitalisations occurred in children <2 years. Receipt of influenza vaccine reduced RSV-hospitalisations, especially in those <2 years with a rate reduction of 2.27 per 1000 (95 % CI: -3.26; -1.28), and a smaller rate reduction of 0.53 per 1000 (95 % CI: -1.04; -0.02) in those 2-7 years. Over the 5-year period (2008-2013), the state-funded preschool-influenza vaccine program resulted in 1,193 fewer RSV-hospitalisations. Of these, 793 (67 %) were in young children <2 years. CONCLUSIONS: To our knowledge, this is the first analysis utilising an IV estimation strategy on a population level to assess the causal impact of seasonal influenza vaccine on risk of RSV-hospitalisations. We estimated a small protective effect that warrants further investigation.
引用
- Le H, de Klerk N, Blyth CC, et al. Non-specific benefit of seasonal influenza vaccine on respiratory syncytial virus-hospitalisations in children: An instrumental variable approach using population-based data. Vaccine. 2023. PMID: 37407408. doi:10.1016/j.vaccine.2023.06.085
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。